ENGLEWOOD, Colo., Feb. 17, 2021 /PRNewswire/ — Paragon 28, Inc. is pleased to announce the launch of MgNum™ Bone Void Filler (BVF). MgNum BVF is designed to fill bony voids and defects that are not intrinsic to the stability of the bone structure. “We are pleased to add MgNum BVF to our diverse biologics portfolio,” stated P28’s...
Paragon 28, Inc. announced today that Stephen Oesterle, M.D. has joined its Board of Directors. “Dr. Oesterle adds extensive experience to our board as both a physician and executive leader at one of the world’s largest medical technology companies,” said Albert DaCosta, Co-Founder, President and Chief Executive Officer, Paragon 28. “We are delighted Steve has...
ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ — Paragon 28 is pleased to announce another addition to its hindfoot fusion portfolio in 2020 with the launch of the Silverback™ Posterior Plating System. The Silverback™ Ankle Fusion Plating System now offers three distinct approaches (anterior, lateral, or posterior). The Posterior Plating System includes 16 low profile anatomically contoured plates...
ENGLEWOOD, Colo., Oct. 6, 2020 /PRNewswire/ — Paragon 28, Inc. is pleased to announce the appointment of Steve Deitsch to the position of Chief Financial Officer. Mr. Deitsch assumes responsibility for finance, accounting, human resources, and information technology. “We are pleased to have Steve on our team,” said Albert DaCosta, Paragon 28, Inc.’s President and Chief Executive Officer. “His financial and...
ENGLEWOOD, Colo., Aug. 19, 2020 /PRNewswire/ — Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefiting...
Paragon 28, Inc., a leading orthopedic foot and ankle company, today announced the completion of a Series B financing. The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of Piper Sandler Companies, and MVM Partners, a healthcare growth equity investment firm. The financing also included participation from an...
Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefiting both the surgeon and patient. Today...
APEX 3D™ marks the next generation in Total Ankle Arthroplasty, with advanced technologies such as porous 3D printed implants and Vitamin E infused highly cross-linked polyethylene. Paragon 28 conducted cutting-edge biomechanical research, including a CT study of arthritic ankles to determine implant geometry and sizing, and a weightbearing CT study of healthy ankles to best...
Expert Surgeons from the Universidad de los Andes, Las Condes, Santiago, Chile conducted a case series on patients who underwent Lapidus MIS procedure for hallux valgus deformity correction with the Phantom® intramedullary nail from April 2018 to October 2019. Read the full article https://scijfootankle.com/JournalFootAnkle/article/view/1158
Paragon 28® launched the TenoTac® Soft Tissue Fixation System in January 2019, providing surgeons the first and only dedicated system to address tendon transfers of the forefoot to correct contracted toes and repair plantar plate. In contrast to traditional methods for flexor tendon transfers, TenoTac® facilitates correction without releasing tissue attachments distally by balancing plantar...
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2025 Paragon 28, Inc.
